Respiratory Pharmacology Flashcards

1
Q

Where are cell bodies of the preganglionic fibres located?

A

Located in the brainstem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a sympathetic response triggered by?

A

External stimuli

Causes smooth muscle relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does a parasympathetic response do?

A

Resets everything

Act through cholingeric neurones to stimulate muscle contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where are the cell bodies of postganglionic fibres located?

A

Embedded in the walls of the bronchi and bronchioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does stimulation of postganglionic cholingeric fibres cause?

A
  • bronchial smooth muscle contraction (mediated by M3 muscarinic ACh receptors on ASM cells
  • Increased mucus secretion mediated by M3 muscarinic ACh receptors on gland (goblet) cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does stimulation of postganglionic noncholingeric fibres cause?

A
  • bronchial sooth muscle relaxation mediated by nitric oxide (NO) and vasoactive intestinal peptide (VIP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Post ganglionic fibres supply what glands and muscle blood vessels?

A
  • Submucosal glands

- Smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does stimulation of autonomic transmitters (sympathetic) cause?

A
  • BRONCHIAL SMOOTH MUSCLE RELAXATION via Beta2-adrenoceptors on ASM cells activated by adrenaline released from adrenal gland
  • DECREASED MUCUS SECRETION mediated by beta2-ADR on gland (goblet) cells
  • INCREASED MUCOCILIARY SECRETION mediated by beta2-ADR on epithelial cells
  • VASCULAR SMOOTH MUSCLE CONTRACTION, mediated by alpha1-ADR on vascular smooth muscle cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Contraction of smooth muscle results from what?

A

Phosphorylation

of the regulatory mysoin light chain (MLC) in the presence of elevated intracellular Ca2+ (and ATP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Relaxation of smooth muscle results from what?

A

Dephosphorylation

of MLC by myosin phosphatase which has constitutive activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What do activities of myosin light chain kinase (MLCK) and myosin phosphatase do to each other?

A

Oppose each other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What happens to the rate of phosphorylation in the presence of elevated intracellular Ca2+?

A

The rate of phosphorylation exceeds the rate of dephosphorylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If the rate of phophorylation exceeds the rate of dephosphoryltion in the presence of elevated intraceullar Ca2+ what does relaxation of smooth muscle require?

A

The return of intracellular Ca2+ concentration to basal level - achieved by primary and secondary active transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is asthma (in the short term)?

A

A recurrent and reversible obstruction to the airways in response to substances that…

  • are not necessarily noxious
  • normally do not affect non-asthmatic subjects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the causes of asthma attacks?

A
  • Allergens (in atopic individuals)
  • Exercise (cold, dry air)
  • Respiratory Infections (e.g. viral)
  • Smoke, dust, environmental pollutants etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the symptoms of asthma? (intermittent attacks of bronchoconstriction)

A
  • tight chest
  • wheezing
  • difficulty in breathing
  • cough
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Chronic asthma involves pathological changes such as…

A
  • increased mass of smooth muscle (hyperplasia and hypertrophy)
  • accumulation of interstitial fluid (oedema)
  • increased secretion of mucus
  • epithelial damage (exposing sensory nerve endings)
  • sub-epithelial fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Airway narrowing by inflammation and bronchoconstriction increase ______ decreasing ______ and ________

A
  • airway resistance
  • FEV1
  • Peak expiratory flow rate (PEFR)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Epithelial damage, exposing sensory nerve endings (C-fibres, inrritant receptors) contributes to what?

A

Increased sensitivity of the airways to bronchoconstrictor influences (and may cause) neurogenic inflammation by the release of various peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the two components of neurogenic inflammation?

A
  • Hypersensitivity

- Hyper-reactivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Provocation tests for hypersensitivity and hyper-reactivity with inhaled bronchoconstrictors e.g. histamine or methacholine reveal what?

A
  • hyper-responsiveness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

In many individuals, an asthma attack comprises what phases?

A
  • immediate (mainly bronchospasm)

- delayed (inflammatory reaction) phases

23
Q

What is IgE associated with?

A

Severe asthma

24
Q

What two general categories do drugs for treating asthma fall into?

A
  • Relievers

- Controllers/ Preventors

25
What do relievers act as?
Relievers act as bronchodilators
26
What are the three types of relievers?
- Short acting beta2_ADR agonists (SABAs) - Long acting beta 2 adrenoreceptor agonists (LABAs) - CysLT1 receprots antagonists
27
What do controllers/ preventors act as?
Act as anti-inflammatory agents that reduce airway inflammation
28
What are the three types of controllers/ preventors?
- Glucocorticoids - Cromoglicate - Humanised monoclonal IgE antibodies
29
What are the bronchodilator drugs used in the treatment of asthma?
- beta2-adrenoceptor agonists - CysLT1 Receptor antagonists - Xanthines
30
Beta2-ADR agonists act as what?
Physiological antagonists of all spasmogens
31
What are the three classifications of beta2-adrenoceptor agonists
- Short-acting (SABA) - Long-acting (LABA) - Ultra long-acting (ultra-LABA)
32
What drugs in the treatment of asthma are anti-inflammatory agents?
Corticosteroids
33
What are the two different types of corticosteroids
- Glucocorticoids | - Mineralcorticoids
34
What do glucocorticoids regulate?
They regulate... - Inflammatory responses - Immunological responses
35
What do mineralocorticoids regulate?
They regulate... | - The retention of salt (and water) by the kidneys
36
Endogenous steroids may possess which kind of actions between glucocorticoids? and mineralocorticoids?
Possess both actions
37
Which corticosteroid action is unwanted in the treatment of inflammatory conditions?
Mineralocorticoid actions
38
What are synthetic divisions of cortisol with little or no mineralocorticoid activity frequently used for?
Used for their anti-inflammatory effect in the treatment of asthma
39
Glucocorticoids are ineffective in relieving what?
- Ineffective in relieving bronchospasm when giving acutely | - Have no direct bronchodilator action
40
Muscarinic Acetylcholine receptors work where?
In the airways
41
What can you do to the parasympathetic neuroeffector transmission to treat COPD?
Reducing parasympathetic neuroeffector transmission with muscarinic receptor antagonists
42
Muscarinic receptor antagonists act as _________ antagonists of bronchoconstriction caused by what?
- Pharmacological | - caused by smooth muscle M3 receptor activation in response to ACh released from postganglionic parasympathetic fibres
43
What blocks muscarinic receptor antagonists?
Activation by ACh of the M3 muscarinic receptor
44
What is the M1 muscarinic receptor expressed for?
M1 Ganglia | - facilitate fast neurotransmission mediated by ACh acting on nicotinic receptors (nAChR)
45
What is the M2 muscarinic receptor expressed for?
M2 Postganglionic Neurone Terminals | - Act as inhibitory autoreceptors reducing release of ACh
46
What is the M3 muscarinic receptor expressed for?
M3 ASM | - Mediate contraction to ACh (also present on mucus-secreting cells evoking increased secretion)
47
What are the five drugs used in the treatment of COPD (Muscarinic Receptor antagonists)
- Ipratropium - Tiotropium - Glycopyrronium - Aclidinium - Umeclidinium
48
Name the short acting muscarinic antagonist(s) (SAMAs)
Ipratropium
49
Name the Long Acting Muscarinic Antagonist(S) (LAMAs)
- Tiotropium - Glycopyrronium - Aclidinium - Umeclidinium
50
How are the drugs used to treat COPD (SAMAs and LAMAs) administered?
Administered by inhalation
51
What does the quaternary ammonium group on the muscarinic anatgonists do?
Reduces absorption and systemic exposure avoiding mutliple potential adverse effects of a generalized parasympathetic block
52
What do muscarinic receptor antagonits do?
- Reduce bronchospasm caused by irritant stimuli - Block ACh-mediated basal tone - Decrease mucus secretion - Little effect on progression of COPD, effect is mainly palliative
53
What is ipratropium?
- non-selective blocker of M1, M2 and M3 receptors | - preferred agents with some selectivity for M3 are available
54
Why are M3 selective blockers superior to Ipratropium?
- Difference in rates of association and dissociation from the M3 receptor